FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Megadyne Recalls Pediatric Return Electrodes

[ Price : $8.95]

Megadyne recalls its Megadyne Mega Soft Pediatric Patient Return Electrodes after receiving reports about patients being burned du...

3 Bayesian Examples Added to Demonstration Project

[ Price : $8.95]

FDA adds three Bayesian statistical analysis examples to the CDER Center for Clinical Trial Innovation Web page.

Supreme Court Rejects Mifepristone Lawsuit

[ Price : $8.95]

The U.S. Supreme Court 6/13 unanimously rejects a lawsuit seeking to sharply restrict distribution of the chemical abortion pill m...

FDA Revises Covid Vaccine Composition Recommendation

[ Price : $8.95]

FDA updates its advice on this falls Covid-19 vaccine composition based on a recent review of circulating Covid cases in the U.S.

Submit Long Covid Drug as IND: FDA

[ Price : $8.95]

FDA says Revive Therapeutics should submit an IND for a clinical trial of its bucillamine as a treatment for Long Covid.

Drug Distribution Security Comment Period Reopened

[ Price : $8.95]

Federal Register notice: FDA reopens the comment period on an 11/20/2023 request for information that is intended to better unders...

Info Collection on Drug Compounding

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Human Drug Compounding, Repackaging, a...

5 Teva ProAir Patents Ordered Out of Orange Book

[ Price : $8.95]

A New Jersey federal judge orders five Teva ProAir patents removed from the FDA Orange Book.

FDA Platform Technology Designation Analyzed

[ Price : $8.95]

Two Morgan Lewis attorneys analyze a recent FDA guidance on how it will implement its drug platform technology designation program...

Positive Results for Setrusumab in Bone Disease

[ Price : $8.95]

Ultragenyx and BioMereo say their setrusumab showed positive results in the Phase 2 portion of the Orbit study in patients with th...